A resource of Calculate by QxMD at https://www.qxmd.com/calculate
Over 400 decision support tools available • get the app for iOS or Android at qx.md/calculate
Supplementary Table 19: Evidence profile of RCTs examining the effect of intrarterial isosmolar vs. low osmolar contrast agent on the prevention of CI-AKI.
Supplementary Table 20: Evidence profile of RCTs examining the effect of intravenous isosmolar vs. low osmolar contrast agent on the prevention of CI-AKI.
Supplementary Table 21: Summary table of RCTs examining the effect of isosmolar vs. low osmolar contrast agent on the prevention of CI-AKI.
Supplementary material is linked to the online version of the paper at http://www.kdigo.org/clinical_practice_guidelines/AKI.php
Do you have an enquiry or suggestion? Get in touch with us through Twitter @QxMD, Facebook QxMD, or email contact@qxmd.com